The product, which is offered within Elucid’s novel Plaque-IQ software suite, allows physicians to analyze lesion composition and plaque burden across any vessel.

The deal includes an upfront payment of $20 million. Stereotaxis could pay up to an additional $25 million if certain regulatory and commercial milestones are met.

The once-daily pill received FDA approval on April 1. However, the agency has requested additional data on multiple potential side effects. 

Stacy Sanso—director of patient access for ARA Diagnostic Imaging, the Austin, Texas, affiliate of Radiology Partners—takes over as president of the association. 

Complaints stemming from such delays prompted officials to look further into the issue, eventually leading them to discover that nearly 200 reports had not been sent to patients’ referring providers. 

“As I step into the role of president, I look forward to continuing strong advocacy for interventional radiologists and ensuring our members are recognized for the value they provide to the healthcare system and improving patient access to high-quality care."

The shift comes after a federal court struck down sweeping changes to the pediatric vaccine schedule that went into effect in 2026. The committee of medical experts, which advises on policy at the Centers for Disease Control and Prevention (CDC), will have to focus on a cost-benefit analysis in its future analyses.

A grand jury in Florida issued the formal charge after being presented with evidence from the prosecution. It is alleged that the death of William Bryan, 70, was a result of Thomas Shaknovsky, MD, removing his liver instead of his spleen.